Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add filters
Database
Language
Document Type
Year range
1.
Development of eruptive pseudoangiomatosis following immunization with COVISHIELD vaccine in an adult.
Prarthana, T; Bakshi, S; Hanumanthu, V; Nahar, U; De, D.
J Eur Acad Dermatol Venereol ; 36(6): e421-e423, 2022 06.
Article in English | MEDLINE | ID: covidwho-1669151

Subject(s)
Angiomatosis , Exanthema , Skin Diseases, Vascular , Vaccines , Adult , ChAdOx1 nCoV-19 , Humans , Immunization
2.
Eruptive angiomatosis after SARS-CoV-2 vaccine (Comirnaty, Pfizer).
Zengarini, C; Misciali, C; Lazzarotto, T; Dika, E.
J Eur Acad Dermatol Venereol ; 36(2): e90-e91, 2022 Feb.
Article in English | MEDLINE | ID: covidwho-1450562

Subject(s)
Angiomatosis , COVID-19 , Exanthema , Angiomatosis/chemically induced , COVID-19 Vaccines , Humans , SARS-CoV-2
3.
Development of eruptive pseudoangiomatosis following COVID-19 immunization - Apropos of 5 cases.
Mohta, A; Jain, S K; Mehta, R D; Arora, A.
J Eur Acad Dermatol Venereol ; 35(11): e722-e725, 2021 Nov.
Article in English | MEDLINE | ID: covidwho-1301508

Subject(s)
Angiomatosis , COVID-19 , Exanthema , Angiomatosis/diagnosis , Humans , Immunization , SARS-CoV-2
4.
Eruptive pseudoangiomatosis and SARS-CoV-2 (COVID-19) infection.
Alonzo Caldarelli, Agostina; Barba, Paula; Hurtado, Mariana.
Int J Dermatol ; 60(8): 1028-1029, 2021 Aug.
Article in English | MEDLINE | ID: covidwho-1180813

Subject(s)
Angiomatosis , COVID-19 , Exanthema , Humans , SARS-CoV-2
SEND TO:
Email
Export
Print
RSS
XML
SELECTION OF CITATIONS
SEARCH DETAIL